The Importance of Seasonal Variants in Community Infection

Rumor has it that the FDA will soon authorize a booster for those at highest risk of developing severe illness. It's not clear, however, that additional doses will be recommended only that they will be available. Lindsay: My own feeling is that it's an easy call for those at the highest risk. They should get boosted. I think that low risk individuals could wait until the fall when there's likely to be a new vaccine formulation.